New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis

Dai Kimura, Jordy Saravia, Sridhar Jaligama, Isabella McNamara, Luan D. Vu, Ryan D. Sullivan, Salvatore Mancarella, Dahui You, Stephania A. Cormier

Research output: Contribution to journalArticle

Abstract

Pulmonary hypertension (PH) has been observed in up to 75% of infants with moderate to severe respiratory syncytial virus (RSV) bronchiolitis and is associated with significant morbidity and mortality in infants with congenital heart disease. The purpose of the present study was to establish a mouse model of PH secondary to RSV bronchiolitis that mimics the disease etiology as it occurs in infants. Neonatal mice were infected with RSV at 5 days of age and then reinfected 4 wk later. Serum-free medium was administered to age-matched mice as a control. Echocardiography and right ventricular systolic pressure (RVSP) measurements via right jugular vein catheterization were conducted 5 and 6 days after the second infection, respectively. Peripheral capillary oxygen saturation monitoring did not indicate hypoxia at 2–4 days post-RSV infection, before reinfection, and at 2–7 days after reinfection. RSV-infected mice had significantly higher RVSP than control mice. Pulsed-wave Doppler recording of the pulmonary blood flow by echocardiogram demonstrated a significantly shortened pulmonary artery acceleration time and decreased pulmonary artery acceleration time-to-ejection time ratio in RSV-infected mice. Morphometry showed that RSV-infected mice exhibited a significantly higher pulmonary artery medial wall thickness and had an increased number of muscularized pulmonary arteries compared with control mice. These findings, confirmed by RVSP measurements, demonstrate the development of PH in the lungs of mice infected with RSV as neonates. This animal model can be used to study the pathogenesis of PH secondary to RSV bronchiolitis and to assess the effect of treatment interventions. NEW & NOTEWORTHY This is the first mouse model of respiratory syncytial virus-induced pulmonary hypertension, to our knowledge. This model will allow us to decipher molecular mechanisms responsible for the pathogenesis of pulmonary hypertension secondary to respiratory syncytial virus bronchiolitis with the use of knockout and/or transgenic animals and to monitor therapeutic effects with echocardiography.

Original languageEnglish (US)
Pages (from-to)H581-H589
JournalAmerican Journal of Physiology - Heart and Circulatory Physiology
Volume315
Issue number3
DOIs
StatePublished - Sep 1 2018

Fingerprint

Bronchiolitis
Respiratory Syncytial Viruses
Pulmonary Hypertension
Pulmonary Artery
Ventricular Pressure
Blood Pressure
Echocardiography
Respiratory Syncytial Virus Infections
Lung
Genetically Modified Animals
Serum-Free Culture Media
Jugular Veins
Infant Mortality
Therapeutic Uses
Catheterization
Heart Diseases
Animal Models
Newborn Infant
Oxygen
Morbidity

All Science Journal Classification (ASJC) codes

  • Physiology
  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis. / Kimura, Dai; Saravia, Jordy; Jaligama, Sridhar; McNamara, Isabella; Vu, Luan D.; Sullivan, Ryan D.; Mancarella, Salvatore; You, Dahui; Cormier, Stephania A.

In: American Journal of Physiology - Heart and Circulatory Physiology, Vol. 315, No. 3, 01.09.2018, p. H581-H589.

Research output: Contribution to journalArticle

Kimura, Dai ; Saravia, Jordy ; Jaligama, Sridhar ; McNamara, Isabella ; Vu, Luan D. ; Sullivan, Ryan D. ; Mancarella, Salvatore ; You, Dahui ; Cormier, Stephania A. / New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis. In: American Journal of Physiology - Heart and Circulatory Physiology. 2018 ; Vol. 315, No. 3. pp. H581-H589.
@article{ff0dae6890674bd2a0ff839ddcbedfd8,
title = "New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis",
abstract = "Pulmonary hypertension (PH) has been observed in up to 75{\%} of infants with moderate to severe respiratory syncytial virus (RSV) bronchiolitis and is associated with significant morbidity and mortality in infants with congenital heart disease. The purpose of the present study was to establish a mouse model of PH secondary to RSV bronchiolitis that mimics the disease etiology as it occurs in infants. Neonatal mice were infected with RSV at 5 days of age and then reinfected 4 wk later. Serum-free medium was administered to age-matched mice as a control. Echocardiography and right ventricular systolic pressure (RVSP) measurements via right jugular vein catheterization were conducted 5 and 6 days after the second infection, respectively. Peripheral capillary oxygen saturation monitoring did not indicate hypoxia at 2–4 days post-RSV infection, before reinfection, and at 2–7 days after reinfection. RSV-infected mice had significantly higher RVSP than control mice. Pulsed-wave Doppler recording of the pulmonary blood flow by echocardiogram demonstrated a significantly shortened pulmonary artery acceleration time and decreased pulmonary artery acceleration time-to-ejection time ratio in RSV-infected mice. Morphometry showed that RSV-infected mice exhibited a significantly higher pulmonary artery medial wall thickness and had an increased number of muscularized pulmonary arteries compared with control mice. These findings, confirmed by RVSP measurements, demonstrate the development of PH in the lungs of mice infected with RSV as neonates. This animal model can be used to study the pathogenesis of PH secondary to RSV bronchiolitis and to assess the effect of treatment interventions. NEW & NOTEWORTHY This is the first mouse model of respiratory syncytial virus-induced pulmonary hypertension, to our knowledge. This model will allow us to decipher molecular mechanisms responsible for the pathogenesis of pulmonary hypertension secondary to respiratory syncytial virus bronchiolitis with the use of knockout and/or transgenic animals and to monitor therapeutic effects with echocardiography.",
author = "Dai Kimura and Jordy Saravia and Sridhar Jaligama and Isabella McNamara and Vu, {Luan D.} and Sullivan, {Ryan D.} and Salvatore Mancarella and Dahui You and Cormier, {Stephania A.}",
year = "2018",
month = "9",
day = "1",
doi = "10.1152/ajpheart.00627.2017",
language = "English (US)",
volume = "315",
pages = "H581--H589",
journal = "American Journal of Physiology",
issn = "0363-6135",
publisher = "American Physiological Society",
number = "3",

}

TY - JOUR

T1 - New mouse model of pulmonary hypertension induced by respiratory syncytial virus bronchiolitis

AU - Kimura, Dai

AU - Saravia, Jordy

AU - Jaligama, Sridhar

AU - McNamara, Isabella

AU - Vu, Luan D.

AU - Sullivan, Ryan D.

AU - Mancarella, Salvatore

AU - You, Dahui

AU - Cormier, Stephania A.

PY - 2018/9/1

Y1 - 2018/9/1

N2 - Pulmonary hypertension (PH) has been observed in up to 75% of infants with moderate to severe respiratory syncytial virus (RSV) bronchiolitis and is associated with significant morbidity and mortality in infants with congenital heart disease. The purpose of the present study was to establish a mouse model of PH secondary to RSV bronchiolitis that mimics the disease etiology as it occurs in infants. Neonatal mice were infected with RSV at 5 days of age and then reinfected 4 wk later. Serum-free medium was administered to age-matched mice as a control. Echocardiography and right ventricular systolic pressure (RVSP) measurements via right jugular vein catheterization were conducted 5 and 6 days after the second infection, respectively. Peripheral capillary oxygen saturation monitoring did not indicate hypoxia at 2–4 days post-RSV infection, before reinfection, and at 2–7 days after reinfection. RSV-infected mice had significantly higher RVSP than control mice. Pulsed-wave Doppler recording of the pulmonary blood flow by echocardiogram demonstrated a significantly shortened pulmonary artery acceleration time and decreased pulmonary artery acceleration time-to-ejection time ratio in RSV-infected mice. Morphometry showed that RSV-infected mice exhibited a significantly higher pulmonary artery medial wall thickness and had an increased number of muscularized pulmonary arteries compared with control mice. These findings, confirmed by RVSP measurements, demonstrate the development of PH in the lungs of mice infected with RSV as neonates. This animal model can be used to study the pathogenesis of PH secondary to RSV bronchiolitis and to assess the effect of treatment interventions. NEW & NOTEWORTHY This is the first mouse model of respiratory syncytial virus-induced pulmonary hypertension, to our knowledge. This model will allow us to decipher molecular mechanisms responsible for the pathogenesis of pulmonary hypertension secondary to respiratory syncytial virus bronchiolitis with the use of knockout and/or transgenic animals and to monitor therapeutic effects with echocardiography.

AB - Pulmonary hypertension (PH) has been observed in up to 75% of infants with moderate to severe respiratory syncytial virus (RSV) bronchiolitis and is associated with significant morbidity and mortality in infants with congenital heart disease. The purpose of the present study was to establish a mouse model of PH secondary to RSV bronchiolitis that mimics the disease etiology as it occurs in infants. Neonatal mice were infected with RSV at 5 days of age and then reinfected 4 wk later. Serum-free medium was administered to age-matched mice as a control. Echocardiography and right ventricular systolic pressure (RVSP) measurements via right jugular vein catheterization were conducted 5 and 6 days after the second infection, respectively. Peripheral capillary oxygen saturation monitoring did not indicate hypoxia at 2–4 days post-RSV infection, before reinfection, and at 2–7 days after reinfection. RSV-infected mice had significantly higher RVSP than control mice. Pulsed-wave Doppler recording of the pulmonary blood flow by echocardiogram demonstrated a significantly shortened pulmonary artery acceleration time and decreased pulmonary artery acceleration time-to-ejection time ratio in RSV-infected mice. Morphometry showed that RSV-infected mice exhibited a significantly higher pulmonary artery medial wall thickness and had an increased number of muscularized pulmonary arteries compared with control mice. These findings, confirmed by RVSP measurements, demonstrate the development of PH in the lungs of mice infected with RSV as neonates. This animal model can be used to study the pathogenesis of PH secondary to RSV bronchiolitis and to assess the effect of treatment interventions. NEW & NOTEWORTHY This is the first mouse model of respiratory syncytial virus-induced pulmonary hypertension, to our knowledge. This model will allow us to decipher molecular mechanisms responsible for the pathogenesis of pulmonary hypertension secondary to respiratory syncytial virus bronchiolitis with the use of knockout and/or transgenic animals and to monitor therapeutic effects with echocardiography.

UR - http://www.scopus.com/inward/record.url?scp=85052946898&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052946898&partnerID=8YFLogxK

U2 - 10.1152/ajpheart.00627.2017

DO - 10.1152/ajpheart.00627.2017

M3 - Article

VL - 315

SP - H581-H589

JO - American Journal of Physiology

JF - American Journal of Physiology

SN - 0363-6135

IS - 3

ER -